Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA SUN PHARMA CIPLA/
SUN PHARMA
 
P/E (TTM) x 33.7 58.2 57.9% View Chart
P/BV x 4.3 5.2 82.7% View Chart
Dividend Yield % 0.5 1.0 46.9%  

Financials

 CIPLA   SUN PHARMA
EQUITY SHARE DATA
    CIPLA
Mar-22
SUN PHARMA
Mar-22
CIPLA/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,083931 116.4%   
Low Rs806593 136.0%   
Sales per share (Unadj.) Rs269.7161.1 167.4%  
Earnings per share (Unadj.) Rs31.714.2 223.5%  
Cash flow per share (Unadj.) Rs44.823.1 193.5%  
Dividends per share (Unadj.) Rs5.0010.00 50.0%  
Avg Dividend yield %0.51.3 40.3%  
Book value per share (Unadj.) Rs257.8200.1 128.8%  
Shares outstanding (eoy) m806.812,399.34 33.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.54.7 74.1%   
Avg P/E ratio x29.853.7 55.5%  
P/CF ratio (eoy) x21.132.9 64.1%  
Price / Book Value ratio x3.73.8 96.3%  
Dividend payout %15.870.4 22.4%   
Avg Mkt Cap Rs m762,1771,827,693 41.7%   
No. of employees `000NANA-   
Total wages/salary Rs m35,29973,008 48.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m217,633386,545 56.3%  
Other income Rs m3,21714,374 22.4%   
Total revenues Rs m220,851400,919 55.1%   
Gross profit Rs m43,29853,150 81.5%  
Depreciation Rs m10,52021,437 49.1%   
Interest Rs m1,0641,274 83.5%   
Profit before tax Rs m34,93344,813 78.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,33810,755 86.8%   
Profit after tax Rs m25,59534,058 75.1%  
Gross profit margin %19.913.7 144.7%  
Effective tax rate %26.724.0 111.4%   
Net profit margin %11.88.8 133.5%  
BALANCE SHEET DATA
Current assets Rs m147,108350,150 42.0%   
Current liabilities Rs m49,129172,006 28.6%   
Net working cap to sales %45.046.1 97.7%  
Current ratio x3.02.0 147.1%  
Inventory Days Days63149 42.2%  
Debtors Days Days6100 5.7%  
Net fixed assets Rs m119,415318,882 37.4%   
Share capital Rs m1,6142,399 67.3%   
"Free" reserves Rs m206,364477,713 43.2%   
Net worth Rs m207,977480,112 43.3%   
Long term debt Rs m4,1622,299 181.0%   
Total assets Rs m266,523669,032 39.8%  
Interest coverage x33.836.2 93.5%   
Debt to equity ratio x00 417.9%  
Sales to assets ratio x0.80.6 141.3%   
Return on assets %10.05.3 189.4%  
Return on equity %12.37.1 173.5%  
Return on capital %17.09.6 177.6%  
Exports to sales %26.20-   
Imports to sales %8.20-   
Exports (fob) Rs m57,094NA-   
Imports (cif) Rs m17,803NA-   
Fx inflow Rs m60,180106,331 56.6%   
Fx outflow Rs m17,80371,874 24.8%   
Net fx Rs m42,37634,456 123.0%   
CASH FLOW
From Operations Rs m33,25989,845 37.0%  
From Investments Rs m-18,719-57,247 32.7%  
From Financial Activity Rs m-15,998-51,935 30.8%  
Net Cashflow Rs m-1,323-17,648 7.5%  

Share Holding

Indian Promoters % 13.5 54.5 24.8%  
Foreign collaborators % 20.1 0.0 -  
Indian inst/Mut Fund % 49.4 35.6 138.6%  
FIIs % 27.7 16.0 173.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.4 45.5 145.8%  
Shareholders   388,864 643,512 60.4%  
Pledged promoter(s) holding % 0.0 2.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    SANOFI INDIA    


More on Cipla vs Sun Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs Sun Pharma Share Price Performance

Period Cipla Sun Pharma S&P BSE HEALTHCARE
1-Day -0.35% 0.07% 0.23%
1-Month -4.65% 4.48% 0.36%
1-Year 14.22% 37.73% -6.87%
3-Year CAGR 33.00% 31.27% 20.16%
5-Year CAGR 12.52% 13.72% 11.07%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the Sun Pharma share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.6% stake in the company. In case of Sun Pharma the stake stands at 54.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of Sun Pharma.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of 15.8%.

Sun Pharma paid Rs 10.0, and its dividend payout ratio stood at 70.4%.

You may visit here to review the dividend history of Cipla, and the dividend history of Sun Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Gains 211 Points | Tyre Stocks Rally while Metals Drag | 4 Reasons Why Indian Share Markets Hit Record High(Closing)

After opening the day lower mirroring weakness in Asian peers, Indian share markets staged a comeback and ended the trading session on an optimistic note.